Prescription of opioids in Italy: everything, but the morphine Oral morphine remains the drug of choice for moderate or severe cancer pain and an important indicator of progress in cancer pain management, according to international guidelines and Cochrane systematic review [1–4]. The available data on the consumption of opioids, particularly of morphine, in Europe apparently show an inappropria...

BACKGROUND The introduction of biological drugs involved a fundamental change in the treatment of rheumatoid arthritis (RA). The extent to which biological drugs are prescribed to RA patients in different regions in Sweden varies greatly. Previous research has indicated that differences in health care practice at the regional level might obscure differences at the individual level. The objectiv...

the aim of the present study was to provide a clear picture of the prescribing pattern of corticosteroids in zanjan, iran. a retrospective and cross-sectional study was conducted to describe the pattern of corticosteroids prescription at beheshti pharmacy (zanjan, iran) over a period of six months between march 21 and september 22 of 2013. descriptive analyses were stratified by gender, age, typ...

Aim: This study was aimed at finding the occurrence rate of prescription errors in the outpatients' prescriptions written by faculty and non-faculty physicians practicing in Shiraz, Iran. Method: In this cross-sectional study 2000 outpatient prescriptions were randomly collected from pharmacies affiliated with Shiraz University of Medical Sciences (SUMS) and social security insurance in Shiraz,...

Identifying the factors and components of an electronic prescription system is of utmost importance in effective designing and implementation of this system. In this regard, the current study was conducted to determine the main factors affecting the national model of electronic prescription from the physicians’ point of view. This is a cross-sectional, descriptive-analytical research carried ou...

BACKGROUND In April/2009, the UK National Health Service initiated four Better Care Better Value (BCBV) prescribing indicators, one of which encouraged the prescribing of cheaper angiotensin-converting enzyme inhibitors (ACEIs) instead of expensive angiotensin receptor blockers (ARBs), with 80 % ACEIs/20 % ARBs as a proposed, and achievable target. The policy was intended to save costs without ...